NURECA
Back to Cashflow Statement
|
NURECA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-20 Cr | ₹-0.17 Cr | ₹-1.30 Cr | ₹-1.51 Cr | ₹-7.30 Cr |
What is the latest Cash Flow from Financing Activities ratio of NURECA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-20 Cr |
| Mar2025 | ₹-0.17 Cr |
| Mar2024 | ₹-1.30 Cr |
| Mar2023 | ₹-1.51 Cr |
| Mar2022 | ₹-7.30 Cr |
How is Cash Flow from Financing Activities of NURECA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-20 Cr | Negative | |
| Mar2025 | ₹-0.17 Cr | Negative | |
| Mar2024 | ₹-1.30 Cr | Negative | |
| Mar2023 | ₹-1.51 Cr | Negative | |
| Mar2022 | ₹-7.30 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NURECA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NURECA | ₹288.8 Cr | -9.1% | -13.8% | -2.8% | Stock Analytics | |
| LENSKART SOLUTIONS | ₹118,621.0 Cr | 8.8% | 1.4% | NA | Stock Analytics | |
| POLY MEDICURE | ₹14,828.2 Cr | 2.2% | -14.3% | -24.1% | Stock Analytics | |
| 3B BLACKBIO DX | ₹1,166.8 Cr | 1% | -6.9% | -1.6% | Stock Analytics | |
| LAXMI DENTAL | ₹980.4 Cr | 2.8% | -9.4% | -43.3% | Stock Analytics | |
| PREVEST DENPRO | ₹456.3 Cr | -1.7% | -0.1% | -26.9% | Stock Analytics | |
NURECA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | -9.1% |
-13.8% |
-2.8% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses